| Literature DB >> 11834837 |
Luciano Di Croce1, Veronica A Raker, Massimo Corsaro, Francesco Fazi, Mirco Fanelli, Mario Faretta, Francois Fuks, Francesco Lo Coco, Tony Kouzarides, Clara Nervi, Saverio Minucci, Pier Giuseppe Pelicci.
Abstract
DNA methylation of tumor suppressor genes is a frequent mechanism of transcriptional silencing in cancer. The molecular mechanisms underlying the specificity of methylation are unknown. We report here that the leukemia-promoting PML-RAR fusion protein induces gene hypermethylation and silencing by recruiting DNA methyltransferases to target promoters and that hypermethylation contributes to its leukemogenic potential. Retinoic acid treatment induces promoter demethylation, gene reexpression, and reversion of the transformed phenotype. These results establish a mechanistic link between genetic and epigenetic changes during transformation and suggest that hypermethylation contributes to the early steps of carcinogenesis.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11834837 DOI: 10.1126/science.1065173
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728